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Human microsporidiosis is a parasitic infection due to species of four different genera: Encephalifozoon; Enterocytozoon; 
Noserna; and Pleistophora. Although well known as a cause of disease in animals, microsporidiosis was only 
occasionally reported in humans. Recently, in human immunodeficiency virus (HIV)-infected patients, microsporidia 
belonging to Encephalifozoon and Enterocytozoon species have proved to be important opportunistic pathogens. 
Enferocytozoon bieneusi is associated with chronic intermittent diarrhea, cholangiopathy and sinusitis whereas 
Encephalifozoon intestinalis, Encephalifozoon hellern and Encephalitozoon cuniculi, the three Encephalitozoon species 
found in humans, are associated with diarrhea, rhinosinusitis, keratoconjunctivitis, nephritis and hepatitis. Diagnosis of 
microsporidial infections in humans was until recently an invasive, laborious procedure including electron microscopy 
of small intestine biopsies. However, new simple staining methods using Uvitex 28 or modified trichrome stain for feces 
and other body fluids have facilitated clinical diagnosis as well as drug evaluation and epidemiological studies. The 
application of monoclonal antibodies and molecular techniques such as the polymerase chain reaction have further 
improved microsporidial diagnosis. Treatment of Entero. bieneusi has, until now, been unsuccessful whereas 
albendazole has proved to be an effective treatment for Encephalifozoon species infection. Identification of effective 
treatment for Enfero. bieneusi infections and further study of the pathogenicity of these rnicrosporidial infections in 
immunocompetent hosts are important future challenges. 
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Human microsporidiosis is a parasitic infection caused 
by species of four different genera, namely, Encephal- 
itozoon, Enterocytozoon, Nosema and Pleistophora, of the 
phylum Microspora. In total, this phylum contains 
approximately 80 genera comprising more than 700 
species. Microsporidia are obligate, intracellular, spore- 
forming protozoa that are ubiquitous in the environ- 
ment and have a host range including most inverte- 
brates and all five classes of vertebrates [1,2]. These 
microorganisms have long been recognized to be a 
cause of disease across a wide range of invertebrate and 
vertebrate hosts, resulting in serious problems for the 
commercial silkworm, honeybee and fishing industries 
[3]. Microsporidia are transmitted from host to host by 
highly resistant spores, which have a unique organiz- 
ation including an infective sporoplasm and a coiled 
polar tube. On adequate stimulation, the polar tube is 
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everted to penetrate the plasma membrane of a suitable 
host cell. The sporoplasm migrates through the hollow 
polar tube into the host cell cytoplasm where replica- 
tion takes place (merogony) before the production of 
spores (sporogony) [2,3]. 
Microsporidiosis in non-HIV-infected humans has 
been only sporadically observed; only eight cases were 
reported in non-HIV-infected patients as of 1989 [2]. 
The first human case involved a 9-year-old Japanese 
boy with a neurological disorder characterized by fever, 
seizures and periods of unconsciousness [4]. Both this 
patient and a similar case reported in 1984 [5] were 
infected by Encephalitozoon species. It is only since the 
advent of the acquired immunodeficiency syndrome 
(AIDS) that microsporidia as a human pathogen have 
received wide interest. 
The first case of microsporidiosis in an AIDS 
patient was reported in 1985 [6]. This patient had 
chronic diarrhea, and the causal parasite was established 
as a new genus and species: Enterocytozoon bieneusi 
[6]. This microsporidian has proven, during the last 
decade, to be the most frequently occurring micro- 
sporidial species diagnosed in AIDS patients. Sinw 
then, other species of the genus Encephahroorr. 
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specifically Encephalitozoon cuniculi, Encephalitozoon 
hellem and Encephalitozoon intestinalis (formerly Septata 
intestinalis), have been recognized to be the second 
most frequently occurring cause of microsporidiosis 
in HIV-infected patients. The remaining two genera, 
Pleistophora and Nosema, are only rarely reported as a 
cause of human microsporidiosis [2,7]. 
Transmission of infection 
The sources of human infection by microsporidial 
species are unknown. Transmission in animals is by the 
fecal-oral route by ingestion of microsporidial spores 
that have been shed into the environment or by 
ingestion of spore-contaminated flesh [3]. There are no 
conclusive data to support human-to-human trans- 
mission of Entero. bieneusi and Encephalitozoon species. 
Animal reservoirs of Entero. bieneusi, Enceph. hellem and 
Enceph. intestinalis have not been reported and Enceph. 
cuniculi, although widespread among animals, has until 
now rarely been found in humans [1,8]. Fecal-oral 
transmission has to be considered a possible route of 
intestinal microsporidiosis in humans [9], although 
inhalation of spore-contaminated aerosolized particles 
may be another route of infection [lo]. Vertical trans- 
mission of Encephalitozoon species is seen in animals, but 
congenital infections in humans have so far not been 
reported [1,3]. 
Occurrence in non-HIV-infected patients 
Thus far, in only eight non-HIV-infected patients 
has a microsporidial infection been reported [2]. In two 
children with neurological disease, Encephalitozoon 
species were isolated fiom cerebrospinal fluid (in one) 
and urine (in both) [4,5]. In a 4-month-old infant with 
thymic aplasia, diarrhea and malabsorption, Nosema 
species was recovered from several organs. Nosema 
corneum was isolated fiom a 45-year-old man fiom 
South Carolina with keratitis [2]; and a Pleistophora 
species was recovered fiom a skeletal muscle specimen 
h m  a 20-year-old patient with myositis [7]. In the 
remaining three cases, all of whom had eye infections, 
microsporidia were identified, although the species 
were not determined [2]. Four of these eight patients 
probably had a form of cellular immunodeficiency [I 13. 
Recently, the first case of Entero. bieneusi infection 
in an HIV-negative patient with acute self-limiting 
diarrhea was reported [12]. We have also observed a 
non-HIV-infected patient with Entero. bieneusi who 
experienced diarrhea for several days from which he 
recovered without treatment (unpublished observ- 
ations). The extent to which Entero. bieneusi, Encepha- 
litozoon species or other microsporidia are involved as a 
cause of disease in non-immunocompromised humans 
remains to be determined. 
In a study by Verre and colleagues [13] of 46 
non-HIV-infected immunosuppressed patients with 
diarrhea, no Entero. bieneusi were found. This is in 
agreement with our finding that Entero. bieneusi 
infection was not present in 168 non-HIV immuno- 
suppressed patients with severe diarrhea (unpublished 
observations). It is likely that Entero. bieneusi is highly 
opportunistic with only a limited patho-genicity in 
immunocompetent patients, as is firther supported by 
our observation that Entero. bieneusi was not found in 
the stool specimens of 288 children with diarrhea sent 
by general practitioners to local medical microbiology 
laboratories for examination for intestinal pathogens 
(unpublished observations). 
Occurrence in HIV-infected patients 
A wide spectrum of infections due to Entero. bieneusi 
and Enceph. intestinalis has been reported in HIV- 
infected patients in Europe, Afiica, South America and 
Australia [8,14-181. The prevalence of Entero. bieneusi 
infection among HIV-positive patients with diarrhea 
varied considerably fiom one center to another, 
ranging from 9 to 50%, and in the diagnostic methods 
used [11,15,18,19]. When duodenal biopsies were used 
for diagnosis, the most fiequently recorded rates of 
prevalence were around 30% [15,19,20]. In The 
Netherlands, with the use of non-invasive diagnostic 
methods and less stringent selection criteria for 
diagnosis (HIV-positive status and diarrhea only), the 
prevalence dropped from 30% to lo%, a percentage 
which remained constant over the last 5 years [19,21] 
(unpublished observations). A similar prevalence (9 to 
16%) has been reported by other workers using non- 
invasive methods to diagnose the presence of Entero. 
bieneusi spores [11,22]. 
Thus far, from Afiica, only a limited number of 
prevalence data (ranging from 1 to 6.5%) of Entero. 
bieneusi have been available [8,23,24]. In a recent study 
in Harare, Zimbabwe, of hospitalized HIV-infected 
patients with diarrhea, 11% of the patients, all of whom 
were adults, were found to be infected with Entero. 
bieneusi. None of the 18 HIV-infected children with 
diarrhea examined had Entero. bieneusi infection [ 171. 
As regards the prevalence of infections caused by 
Encephalitozoon species - in particular, Enceph. hellem 
and Enceph. intestinalis - few data are avadable. The 
prevalence of such infections, obtained from studies 
applying invasive or non-invasive diagnostic methods, 
ranged from 2.6 to 3.7 % [8,14,15,21]. These figures 
indicate a much lower frequency of infection due to 
these species than that recorded for Entero. bieneusi. 
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CLINICAL MANIFESTATIONS AND PATHOLOGY 
Infection due to Enterocytozoon bieneusi 
Infection due to Entero. bieneusi in AIDS patients is 
associated with a persistent diarrhea [18,19,25-271. 
This diarrhea has a chronic and intermittent character, 
often with alternating symptomatic and asymptomatic 
days [19] (J.K.M. Eeftlnck Schattenkerk, personal 
communication). The severity of the diarrhea can vary 
from one to six loose-to-liquid stools, normally 
without blood or mucus. The intermittent character of 
the diarrhea is typical of Entero. bieneusi infections and 
contrasts with Cryptosporidium infections in AIDS 
patients in which frequent and voluminous intractable 
diarrhea is often observed [19]. Anorexia and nausea are 
frequently reported in Entero. bieneusi infection, as is 
cramping abdominal pain before defecation. Fever is 
not a part of the clinical syndrome [19]. 
The principal sites of Entero. bieneusi infection are 
the duodenum and jejunum, with only occasional 
infection of the sigmoid colon and rectum [25,26, 
28,291. The mucosa of the small intestine shows a wide 
spectrum of hisropathology, ranging from a normal 
architecture with no significant inflammatory changes 
to significant villus flattening with decreased villus- 
to-crypt ratios [18,19,29]. Although parameters of 
absorption, especially of fat and D-xylose, is highly 
abnormal in most patients with Entero. bieneusi in- 
fection, the pathogenesis of the infection remains 
unclear [18,26,27]. Mucosal cytokine-mediated in- 
flammatory responses do not play an important role 
in the pathogenesis of Entero. bieneusi-associated 
diarrhea [30]. 
On the basis of recent studies examining small 
intestine biopsies, there is no correlation between the 
parasite load, histopathology of the duodenal mucosa 
and severity of diarrhea in patients with Entero. bieneusi 
infection [20,29]. However, with study of only a 
limited number of small intestine biopsies, neither the 
parasite load nor histopathology is well ascertained, as 
the usual distribution of Entero. bieneusi in the small 
intestine appears to be often focal [28,29]. In follow- 
up studies of patients with Entero. bieneusi using non- 
invasive diagnostic methods, we observed that some 
patients with huge parasite loads in their fecal specimen 
[50 to 75 sporedhigh-power field (X  1250, light 
microscopy)] did not report complaints of diarrhea over 
prolonged periods of time (unpublished observations). 
This observation supports the contention that the 
intensity of Entero. bieneusi infection may in some cases 
be unrelated to the presence and severity of diarrhea 
[20]. Thus, it is possible that other, as yet undiscovered, 
factors may contribute to the pathogenesis of Entero. 
bieneusi-associated diarrhea [20,29]. 
Enterocytozoon bieneusi was observed in the nasal 
discharge and sinus aspirate fiom a patient with chronic 
rhinosinusitis [10,31], and in the bronchoalveolar 
lavage fluid and transbronchial lung biopsies from a 
patient with chronic cough and dyspnea. Both patients 
also had Entero. bieneusi in the small intestine. An 
association between the clinical symptoms and the 
presence of the parasite could not be established with 
certainty [ 101. 
Enterocytozoon bieneusi has also been found in the 
biliary tract [32,33]. In AIDS patients with signs of 
cholangiopathy, the organism was found in epithelial 
cells of the common bile duct and gallbladder, in 
ductal biliary cells and in bile [32,33]. Infiltration of 
the lamina propria by mononuclear cells has been 
associated with Entero. bieneusi infection of bile duct 
epithelium [32]. Although a causal relationship bet- 
ween microsporidial infection of the biliary tract and 
AIDS-related cholangitis is difficult to prove, the 
presence of Entero. bieneusi in the affected organs and 
bile in the absence of other known pathogens is 
suggestive of a causative role for this parasite in these 
infections. Although Entero. bieneusi has been reported 
in specimens from various sites and organs, there is as 
yet no evidence of dissemination of Entero. bieneusi 
beyond the superficial epithelial cell lining. 
In general, Entero. bieneusi infections have been 
recorded in HIV-infected patients with severe im- 
munodeficiency [18,19]. Most patients with Entero. 
bieneusi infection have CD4 counts of less than 50/pL 
although, occasionally, counts up to 600/$ have been 
reported [18,19,29,30]. These data support the view 
that Entero. bieneusi appears to have an opportunistic 
character yith pathogenicity only in severely immuno- 
suppressed HIV-infected patients. 
Infection due to Fncephalitozoon species 
Infection caused by Encephalitozoon species differs 
considerably from that due to Entero. bieneusi because 
of the ability of the former species to disseminate from 
the site of entry, most likely the intestine or respiratory 
tract, to various organs [1,34-361. The genus consists 
of three species - Enceph. cuniculi, Enceph. hellem and 
Enceph. intestinalis (the latter was formerly known as 
Septata intestinalis, but was recently reclassified on the 
basis of genetic and immunological stuhes) [37]. 
Although Enceph. cuniculi has been implicated as 
a major cause of disease in animals such as rabbits 
and monkeys [1,38], the species has only recently 
been hagnosed in an HIV-infected patient [8]. In 
earlier reports of presumed Enceph. cuniculi infection 
in humans [5,39,40], species determination was not 
carried out according to current knowledge and 
methodology. Furthermore, Enceph. cuniculi was the 
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only species of the genus known at that time. In 
studies using recently developed methods for genetic 
and immunological characterization of the dfferent 
Encephalitozoon species, Enceph. hellem and especially 
Enceph. intestinalis proved to be the most frequently 
occurring Encephalitozoon species in human micro- 
sporidiosis [41-44]. The majority of patients with 
Enceph. intestinalis and Enceph. hellem infections are 
severely immunocompromised with CD4 lymphocyte 
counts ranging fiom 0 to 70/fi  [35,41,45,46]. 
Recent studies indicate that the spectrum of disease 
associated with Encephalitozoon infection overlaps 
considerably among the three species. Both Enceph. 
hellem and Enceph. intestinalis have been reported to be 
associated with chronic rhinosinusitis [31,41,45,47], 
tubulointerstitial nephritis and urethritis [41,44,46,48]. 
Encephalitozoon hellem has also been reported in the 
lower respiratory tract from the tracheobronchial 
epithelium and terminal bronchioles [44,49]. We 
recently observed Enceph. intestinalis in bronchoalveolar 
fluid fiom an HIV-infected patient with clinical signs 
of persistent severe bronchitis (unpublished obser- 
vations). Although both Enceph. hellem and Enceph. 
intestinalis appear to colonize the tracheobronchial 
epithelium, evidence of alveolar disease has not been 
observed [36,49] (unpublished observations). Asymp- 
tomatic colonization of the urinary tract with these two 
species is also probably more common than overt renal 
pathology [21,36,41]. 
The most fiequent site of Enceph. hellem infection 
is the eye. The infection usually involves bilateral 
keratoconjunctivitis accompanied by photophobia, 
decreased visual activity or lacrimation [50,51]. Coarse 
punctate epithelial keratopathy is nearly always seen on 
slit-lamp examination [52]. In the eye, Enceph. hellem 
appears to be restricted to the epithelium of the 
conjunctiva and cornea, but has not been observed in 
the stroma. Infections of the deep corneal stroma 
have been reported exclusively in non-HIV-infected 
patients and are caused by other microsporidial species, 
including N. corneum, Nosema-like species and unclassi- 
fied microsporidia [51-551. 
The principal site of Enceph. intestinalis infection is 
reported to be the small intestine, especially the distal 
duodenum and proximal jejunum [21,35,41,56]. A 
recent study also reported this species in the terminal 
ileum and large bowel, in one case associated with 
severe colitis [41]. Several reports suggested an 
association between Enceph. intestinalis infection in the 
intestine and diarrhea [21,27,34,35,41,57]. Fever has 
been reported in Enceph. intestinalis infections, but 
whether this is caused by the microsporidial parasite or 
by other concomitant opportunistic infections is not 
clear [35,57]. 
To what extent the Encephalitozoon species are 
associated with disease of the liver remains to be 
elucidated. There have been several reports of Enceph. 
intestinalis in association with cholangitis, granulous 
inflammation and marked necrosis of the affected 
tissue [35,58]. Presumed Enceph. cuniculi infection was 
observed in a patient with hepatitis and in another 
patient with peritonitis [39,40]. 
LABORATORY METHODS FOR DIAGNOSIS 
With the recent introduction of fast, non-invasive, 
light-microscopy methods, the routine diagnosis of 
Enterocytozoon and Encephalitozoon species infections has 
become feasible by clinical microbiology laboratories 
[21,59,60]. Because these methods do not require 
an invasive procedure and have a proven reliability 
[21,60-62], they should be used for the initial diagnosis 
of microsporidial infections in stool, urine, nasal 
discharge and other body fluids. The use of tissue 
biopsies initially in the routine diagnosis of micro- 
sporidiosis should be regarded as an obsolete procedure 
causing unnecessary inconvenience to the patient and 
should only be used in special circumstances. The 
methods in use for diagnosis of Entero. bieneusi and 
Encephalitozoon species infections include non-specific 
and specific (confirmation) assays, and serological 
methods. 
Non-specific methods for diagnosis of microsporidiosis in 
body fluids 
In 1990, we reported a simple procedure to diagnose 
microsporidial spores of Entero. bienensi in stool speci- 
mens [9]. Using Giemsa staining, the spores were 
visible as broad oval structures with a pale greyish-blue 
cytoplasm and deep purple nucleus. Adjacent to the 
nucleus is a clear area. By this method, the estimated 
spore dmensions are 1.1 to 1.6 X 1 . 0 ~  [9]. 
Although this new diagnostic method proved to be 
useful in clinical practice [21], recognizing the spores 
among the bacterial flora remained difficult. 
In 1992, Weber and coworkers [60] described a 
technique using a modified trichrome stain (MTS), 
to which several modifications have recently been 
described [62,63]. With the MTS, the spores appear 
pinkish-red, sometimes with a pinkish-red belt-like 
stripe that girds the spores diagonally or equatorially 
[60], and the background stains green. Using this 
method, the size of the spores is approximately 1.5 x 
0.9 pm. Yeasts and some bacteria may also take up the 
stain, but are differentiated from the microsporidial 
spores by differences in size, shape and intensity of 
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staining [60]. Although this method is laborious and 
lengthy to perform, it is an improvement over the 
Giemsa stain technique because of the improved 
discrimination between microsporidial spores and 
background. The MTS method proved to be reliable 
for detecting Entero. bieneusi and Encepkalitozoon species 
in feces and other body fluids, and is widely used in 
clinical microbiology laboratories [60,62,63]. 
Recently, we described a new diagnostic method 
in which the chitinous inner layer of the microsporidial 
spore is stained with the fluorescent stain Uvitex 2B 
[21]. The spores of Entero. bieneusi and Encepkalitozoon 
species fluoresce brightly white against a dark back- 
ground. An important differential characteristic of 
Entero. bieneusi spores is a concave inner stripe and 
shadow. This stripe is less frequently observed in spores 
of Encepkalitozoon species [21]. The clear area seen with 
Giemsa staining, the belt-like stripe on MTS staining 
and the concave inner stripe with Uvitex 2B probably 
represent the same structure in the spore. This could be 
a partially collapsed inner spore wall as a result of 
discharge of the spore contents into the environment 
[21]. An important observation is that the shape and 
size of mature spores of Entero. bieneusi (broad ovals 
approximately 1.6 X 1.0 p) show little variation in 
contrast to the larger spores of Encepkalitozoon species, 
which vary considerably in both shape and size, being 
broad and rod-like or kidney-shaped, and ranging from 
2.5 to 3.3 X 1.3 to 2.1 pm [21]. 
The Uvitex 2B method proved to be fast, sensitive 
and simple to perform [21,22,35,41,42,64]. In com- 
bination with a water-ether sedimentation (WES) 
concentration method, the sensitivity of the method 
was further improved with an easier application in 
routine laboratories [59]. To examine HIV-infected 
patients with diarrhea €or Entero. bienensi infection, one 
feces sample, prepared with the WES-Uvitex 2B 
method, is sufficient for a reliable diagnosis. Although 
there is considerable day-to-day variation in spore- 
shedding in stool, the sensitivity of this method has 
proved sufficient for detection of spores even on days 
with low spore-shedding [21,59]. During the last 4 
years, we have never observed a negative follow-up 
sample in cases where Entero. bieneusi was initially 
dagnosed [21 ] (unpublished observations). As an 
alternative for Uvitex 2B, the fluorochrome calcofluor 
white has been used [65] which, although equally 
effective in staining microsporidia, is probably more 
difficult to interpret because of a considerably greater 
background fluorescence [64]. 
By emphasizing the presumed advantages of MTS 
compared with Uvitex 2B staining [ll], much un- 
certainty as to the reliability of stool diagnosis of 
microsporidiosis in general has arisen [66]. Because 
both MTS and Uvitex 2B stains are non-specific, strict 
adherence to precise diagnostic criteria (size, shape, 
belt-like stripe, concave inner stripe) is necessary to 
avoid incorrect results [21,60]. With the use of precise 
morphological criteria, as is the normal practice in 
parasitology laboratory diagnosis, it has been established 
that, after appropriate training, the morphological 
details with both methods can be well applied in 
routine laboratory practice [21,35,41,42,57,60]. 
Whereas the MTS method needs only a regular 
light microscope, a fluorescence microscope is neces- 
sary for the Uvitex 2B technique. The time required 
for staining (10 min) and reading (1 to 2 min) the slides 
with Uvitex 2B stain is short compared with the MTS 
method, which requires a preparation time of approxi- 
mately 2 h, including laborious dehydration steps [60]. 
The Uvitex 2B method has proved to be more sensitive 
than the MTS [22,64]. Furthermore, the use of 
calcofluor white instead of Uvitex 2B appears to be 
more sensitive than MTS [65]. 
It is suggested that the Uvitex 2B staining method 
could be used as the more rapid, easier and more 
sensitive screening technique, with the MTS and 
Giemsa staining methods in reserve as additional 
methods [64] (E.U. Canning, personal communi- 
cation). The simultaneous use of both the Uvitex 2B 
and MTS methods is indeed reported with increasing 
frequency [35,41,42,57,64]. Whatever method is used, 
appropriate training of laboratory personnel in the 
proper handling of these methods remains the corner- 
stone of reliable microsporidial diagnosis. More 
attention should be given to this aspect of training than 
to the presumed (dis)advantages of the two methods. 
With. both the Uvitex 2B and MTS methods, 
Entero. bieneusi infection can also be reliably diagnosed 
in other body fluids such as nasal discharge or bile 
samples [3 1,331. 
Large numbers of Encepkalitozoon spores can be 
reliably detected by either MTS or Uvitex 2B staining 
[21,35]. However, difficulties in diagnosis arise 
especially in stool specimens with low numbers of 
spores. Because the morphology of Encepkalitozoon 
spores is more variable than that of Entero. bieneusi, the 
characteristic morphological features - such as the 
concave inner stripe - are less fi-equently observed and 
diagnosis with either MTS or Uvitex 2B may be 
inconclusive in such cases. 
Non-specific methods for diagnosis of microsporidiosis in 
tissue specimens 
Before the introduction of non-invasive diagnostic 
methods, biopsies of the duodenum and proximal 
jejunum were routinely used for diagnosis of micro- 
sporidial infections. A wide variety of non-specific 
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staining methods has been described for this purpose. 
These have included toluidine blue staining on 
semithin resin-embedded sections [56], and paraffin- 
embedded sections stained with haematoxylin-eosin, 
Giemsa, the Brown-Hopps variants of Gram’s, periodic 
acid-Schiff and Grocott methenamine-silver stains 
[15,56,67]. A promising method is the Warthin-Starry 
stain applied to paraffin-embedded sections. This 
method stains both Entwo. bieneusi and Encephalitozoon 
species, even when the latter are within macrophages 
[15]. We have described a fast and simple method in 
which biopsy tissue is teased apart with two fine needles 
to provide a thin smear on a slide which, after fixation 
with methanol, is stained with Giemsa [19,68,69]. 
Uvitex 2B staining has also been used for diagnosis of 
microsporida in biopsies (C. Sarfati, HGpital Saint 
Louis, Paris, personal communication). 
Specific methods for diagnosis of microsporidiosis 
Electron microscopy 
The newly introduced staining methods, such as MTS 
and Uvitex 2B, have decreased the use of electron- 
microscopy (EM) for diagnosis of microsporidia in 
routine practice. However, in special circumstances, 
such as when diagnosing microsporidial infections in a 
tissue location not previously reported, when studying 
the effects of drug treatment or when a new micro- 
sporidial species appears to be involved, then EM is 
needed for confirmation. EM is the ~ n l y  method with 
which the characteristic developmental stages of 
microsporidia in tissue can be accurately studied 
[6,34,50,70-721. Of the Encephalitozoon species, 
Erueph. hellem and Enceph. cuniculi cannot be differen- 
tiated from each other by EM alone [6,34,70]. 
EM can also be used successfully for the confirm- 
ation and, to a lesser extent, determination of micro- 
sporidia in feces and body fluids although, most often, 
only (damaged) spores and no other developmental 
stages can be seen [9,31,33]. The unique organization 
of the microsporidial spores, including an inner coiled 
polar tube, enables their rapid identi-fication [9]. 
Spores of Entero. bieneusi are small (0.5 X 1.5 p) and 
oval in shape [6], with a polar tube that forms 
approximately s i x  coils in a characteristic double 
arrangement of three coils [9,72]. The spores have one 
nucleus, an electron-lucent endospore layer (ofien thin) 
and an outer electron-dense exospore coat [6,72]. In 
contrast, spores of Enceph. cuniculi, Enceph. hellem and 
Enceph. intestinalis (approximately 1.8 X 1.0 p) are 
larger and have four to nine (but usually five) polar tube 
coils arranged in a row, one nucleus, a thick electron- 
lucent endospore and a thin electron-dense exospore 
[34,43,70]. Spores of these three Encephalitozoon species 
cannot be differentiated from each other in clinical 
specimens with EM. 
Although EM remains the ‘gold standard’ for 
microsporidial diagnosis, the procedure is laborious 
and expensive. 
Specific antibodies 
For rapid confirmation and determination to species 
level of a suspected Encephalitozoon infection in a 
clinical specimen, monoclonal antibodies (MAbs) 
against Enceph. hellem and Enceph. intestinalis are now 
available [73-751. Polyclonal mouse and rabbit anti- 
bodies against Enceph. hellem, Enceph. intestinalis and 
Enceph. cuniculi are also avaliable for diagnosis of micro- 
sporidia in body fluids and biopsies, but cross-reactivity 
of these sera with the three Encephalitozoon species and 
Entero. bieneusi limits their use to differentiate these 
species [52,67,74-761. 
Molecular techniques 
Molecular techniques such as the polymerase chain 
reaction (PCR), restriction f ixpent  length poly- 
morphism (RFLP) and gene sequencing have recently 
been used for diagnostic and taxonomic studies of 
human microsporidial infection [37,75,78-831. To 
confirm the diagnosis and identi6 the species of 
Encephalitozoon involved, a PCR of rn genes, encodng 
s m a l l  subunit ribosomal RNA, combined with RFLP 
of the amplified product has proved to be successful 
[37,80]. The small subunit rRNA gene of Entero. 
bieneusi has also recently been used as a target for 
drect diagnosis in body fluids and tissue specimens 
[79,83]. 
For the moment, however, for routine diagnosis of 
Entero. bieneusi and Encephalitozoon species in clinical 
specimens, MTS, Uvitex 2B or histological staining 
methods in combination with the newly available 
specific MAbs against Enceph. hellem and Enceph. 
intestinalis provide speed and simplicity compared 
with the currently laborious and expensive molecular 
techniques. Unknown inhibiting factors, especially in 
stool specimens, further limit the usefulness of 
the molecular techniques for routine diagnosis 
(unpublished observations). The high sensitivity and 
specificity of the molecular techniques could be of 
benefit in the diagnosis of Encephalitozoon infection in 
certain clinical samples such as urine and cerebrospinal 
fluids, where spore-shedding is reported to be inter- 
mittent [1,5]. In addition, these techniques appear to 
be in monitoring the efficacy of albendazole treatment 
in urine (unpublished observations). 
Molecular techniques have proved to be impor- 
tant for taxonomic studies [37,82]. A comparison of 
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sequence data from genes encodmg regions of small and 
large ribosomal DNA of Etueph. cuniculi and Enceph. 
hellem showed a relatively high sequence similarity, 
supporting the proposal to place these two species into 
the same genus [82]. Hartskeerl and colleagues [37] 
used the unique sequence of ws genes of S. intestinalis 
as well as the distinctive RFLP patterns together with 
sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) protein profiles to 
reclassltjr S. intestinalis as Enceph. intestinalis [37]. 
In vitro cultivation 
In vitro cultivation of microsporidia combined with 
EM has been used for diagnosis and species determin- 
ation of human microsporidial infections [43,54,70]. 
With the availabhty of the new MAbs against Enceph. 
hellem and Enceph. intestinalis as well as molecular 
techniques, the need for this laborious procedure as 
a clinical diagnostic tool has largely disappeared 
[37,73,74,80]. Despite this, in vitro cultivation of 
human isolates remains of great importance in the 
preparation of specific antibodies and development of 
new molecular techniques. 
Thus far, Entero. bieneusi has not been cultivated in 
vitro. We have observed a short period of reproduction 
of this species in cell culture systems, but prolonged 
cultivation was not established (unpublished results). 
Of  the microsporidia reported from humans, Enceph. 
cuniculi, Enceph. hellem and N. corneum have been 
successfully cultivated in vitro [8,50,54]. Recently, we 
succeeded for the first time in cultivating Enceph. 
intestinalis in vitro [43]. 
Serology 
Until now, serological methods received little attention 
for the diagnosis of microsporidiosis in humans 
[1,2,5,17,84-861. Serology using Encephalitozoon and 
Nosema species as antigens was performed on only a few 
non-HIV-infected patients with EM-proven micro- 
sporidiosis, and revealed variable titers and cross- 
reacting antibodies [5,84]. Serological surveys with 
Enceph. cuniculi as antigen showed high prevalences 
of antibody titers among patients with tropical 
diseases and renal and neurological disorders [l]. It is 
uncertain whether these data represent infection, cross- 
reactivity to other microsporidial species or non- 
specific reactions [2]. 
A recent study where enzyme-linked immuno- 
sorbent assay (ELISA) and Western blotting were 
assessed for their use in the diagnosis of sera h m  HIV- 
infected patients with proven Encephalitozoon infection, 
there was considerable variation in antibody titers, from 
high to very low [84]. The cross-reactivity observed 
when human sera were tested with different micro- 
sporidia as antigen limited any conclusive data con- 
cerning the species involved [84]. The study concluded 
that the diagnosis of microsporidiosis in HIV-infected 
patients should be based on direct detection of the 
organism rather than on conventional serology [84]. 
TREATMENT 
Enterocytozoon bieneusi infection 
Although a clinical response afier treatment of Entero. 
bieneusi has been reported, eradication of the parasite 
from the infected site has never been documented 
[19,87-891. Recently, the use of albendazole (400 mg 
twice daily orally for 4 weeks) was propagated as an 
effective drug in HIV-positive patients with Entero. 
bieneusi, and reported to result in a decrease in the 
number of bowel movements and weight gain 
[87,88,90]. Also, a decrease in the parasite load in the 
intestine and damage to developmental stages, leading 
to partial inhibition of parasite reproduction, was 
noticed [87,88,90]. However, in none of the studies 
was Entero. bieneusi eradicated from the intestine. The 
degenerative changes in growth stages of Entero. bieneusi 
observed in earlier studies [87] were not seen in a later 
study [88]. In addition, a decrease in parasite load as 
measured from a limited number of biopsies should be 
regarded with caution in view of the wide -day-to-day 
variation in spore-shedding in untreated patients 
and the focal localization of the infection in the 
small intestine [21,29,88]. With high-dose albendazole 
(1800 mg/day for 4 weeks), Entero. bieneusi was not 
eradicated from feces [31]. 
Assessment of the effect of albendazole on Entero. 
bieneusi-associated diarrhea requires double-blind 
placebo-controlled studies. As such studies are lacking, 
albendazole should be regarded as an agent that could 
provide temporary symptomatic relief of diarrhea in a 
number of Entero. bieneusi-infected patients. Symp- 
tomatic relief in Entero. bieneusi infection has also 
been described with thalidomide and metronidazole 
[19,91]. 
bcephditozoon species infection 
Albendazole treatment has proved effective in Enceph. 
hellem and Enceph. intestinalis infections, yielding quick 
and complete eradication of the parasite from infected 
sites [21,31,35,41,57,89]. Albendazole has also shown 
marked activity against Enceph. cuniculi in vitro [92]. 
Patients with Enceph. intestinalis infection of the 
intestine, nasal mucosa and renal tissue with signs of 
diarrhea, chronic rhinosinusitis and renal failure, 
respectively, showed a rapid clinical response after 
albendazole treatment [21,31,41,46,57]. The dose of 
albendazole was, in most cases, 400 mg orally twice 
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daily [21,31,35,41] and the duration of treatment 
varied from 8 days to 4 weeks [21,31,35,41] with, 
occasionally, a lower dose of 400 mg daily for 16 weeks 
Relapse after albendazole treatment, possibly due 
to reactivation of remaining spores unaffected by 
treatment, has been recorded in several cases [21,35]. It 
is clear that the albendazole dosage and duration of 
treatment needs to be better defined in clinical trials 
[35]. Whether maintenance therapy with albendazole 
is indicated remains controversial. Among albendazole- 
treated patients, a high relapse rate of infection can 
be expected. However, the signs and symptoms of 
Encephalitozoon infections are, as far as we know, ofien 
relatively mild and slow to progress. Therefore, regular 
monitoring of urine and feces for Encephalitozoon spores 
to establish recurrence of infection may indicate 
whether retreatment is necessary, thereby avoiding 
the addition of yet another drug to the many already 
continuously taken by HIV-infected patients. 
Keratoconjunctivitis associated with Enceph. hellem 
in HIV-positive patients can be treated with topical 
fumagdhn (Fumidil B) [93,94]. Although the spores 
persist during hmagillin treatment, a marked clinical 
improvement can be achieved as long as the treatment 
is continued. No toxic side effects have been reported 
with prolonged treatment [93]. Symptomatic relief of 
keratoconjunctivitis caused by Encephalitozoon species 
was also reported with both propamidine isethionate 
(0.1%; Brolene) and itraconazole [95,96]. 
[571. 
FUTURE CHALLENGES 
From the clinical point of view, the most important 
challenge at present is to find effective treatment of 
Entero. bieneusi infection. As a model for quick drug 
screening, in-vitro cultivation of this parasite is urgently 
required. Because of the well-established effects of 
albendazole on Encephalitozoon infections, studies seek- 
ing new drugs for these infections lack a high priority. 
Refinement of the dose regimens of albendazole are, 
however, still needed. 
Although diagnosis of Entero. bieneusi infections is 
currently well covered by fast and simple non-invasive 
methods, such as the MTS and Uvitex 2B staining 
techniques, improvement of diagnostic methods for 
Encephalitozoon infections is still required especially to 
explore other, as yet unknown, sites of infection. 
From reports describing the pathology associated with 
microsporidial infection in animals, it is anticipated that 
the central nervous system is a potential site of 
Encephalitozoon infection [38]. 
The pathology associated with Entero. bieneusi and 
Encephalitozoon infections in non-HIV-infected patients 
is still largely unknown, although Entero. bieneusi 
probably has only limited pathogenicity in immuno- 
competent hosts. A most intriguing question is 
whether Encephalitozoon species, given their dis- 
seminating character, are pathogens in immuno- 
competent subjects. New serological methods, as 
recently developed in our laboratory, are likely to prove 
invaluable in answering this question. 
The epidemiology of microsporidia in humans is 
still largely unknown [l]. Sources of human infection 
by Entero. bieneusi and Encephalitozoon species have not 
yet been established, although transmission between 
humans through urine, feces, nasal discharge or 
sputum has been postulated [31,36,42,93]. In addition, 
extended ultrastructural. antigenic and genetic analyses 
of Encephalitozoon isolates fbm clinical specimens are 
needed to elucidate the heterogeneity in and between 
species isolated from different patients in Werent parts 
of the world. 
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